Excelsior Medical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 10, 2023 at 03:52 am EST
Share
Excelsior Medical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 2,019.82 million compared to TWD 1,841.14 million a year ago. Net income was TWD 183.32 million compared to TWD 201.63 million a year ago. Basic earnings per share from continuing operations was TWD 1.18 compared to TWD 1.3 a year ago. Diluted earnings per share from continuing operations was TWD 1.18 compared to TWD 1.29 a year ago.
For the nine months, sales was TWD 6,048.63 million compared to TWD 5,223.76 million a year ago. Net income was TWD 558.22 million compared to TWD 509.75 million a year ago. Basic earnings per share from continuing operations was TWD 3.59 compared to TWD 3.28 a year ago. Diluted earnings per share from continuing operations was TWD 3.57 compared to TWD 3.26 a year ago.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.
EXCELSIOR MEDICAL CO., LTD. 
